
Ferric carboxymaltose (FCM) improves left ventricular (LV) function in heart failure with reduced ejection fraction (HFrEF). Yet, the effect of FCM on right ventricular (RV) function remains insufficiently elucidated. Treatment with FCM in HFrEF patients improves RV function and structure and improves the RV‐contractile reserve.
Like
Save
Share